Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis

Journal of Immunology

Volumn 175, Issue 7, 2005, Pages 4392-4399

  Curtsinger, Julie M ^a   Lins, Debra C ^a   Johnson, Christopher M ^a   Mescher, Matthew F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GRANZYME B; INTERLEUKIN 12; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PERFORIN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; DEGRANULATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 25444468825     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.7.4392     Document Type: Article

References (41)

1. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165: 6833-6839.
2. Wong, P., and E. G. Pamer. 2001. Cutting edge: antigen-independent CD8 T cell proliferation. J. Immunol. 166: 5864-5868.
3. van Stipdonk, M. J., E. E. Lemmens, and S. P. Schoenberger. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol 2: 423-429.
4. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2: 415-422.
5. + T cells responding to self-antigens. J. Exp. Med. 196: 323-333.
6. + T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194: 707-717.
7. Lauvau, G., S. Vijh, P. Kong, T. Horng, K. Kerksiek, N. Serbina, R. A. Tuma, and E. G. Pamer. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294: 1735-1739.
8. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192: 63-75.
9. Lee, P. P., C. Yee, P. A. Savage, L. Fong, D. Brockstedt, J. S. Weber, D. Johnson, S. Swetter, J. Thompson, P. D. Greenberg, et al. 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med. 5: 677-685.
10. Blohm, U., E. Roth, K. Brommer, T. Dumrese, F. M. Rosenthal, and H. Pircher. 2002. Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes. J. Immunol. 169: 5522-5530.
11. Curtsinger, J. M., D. C. Lins, and M. F. Mescher. 2003. Signal 3 determines tolerance versus full activation of naive CDS T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197: 1141-1151.
12. + T cells. J. Immunol. 162: 3256-3262.
13. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Cutting edge: type I interferons provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174: 4465-4469.
14. Curtsinger, J. M., C. M. Johnson, and M. F. Mescher. 2003. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171: 5165-5171.
15. Schmidt, C. S., and M. F. Mescher. 2002. Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12. J. Immunol. 168: 5521-5529.
16. + T cells in vivo. J. Immunol. 163: 2561-2567.
17. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
18. Watford, W. T., M. Moriguchi, A. Morinobu, and J. J. O'Shea. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14: 361-368.
19. Valenzuela, J. O., C. D. Hammerbeck, and M. F. Mescher. 2005. Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells. J. Immunol. 174: 600-604.
20. Valenzuela, J. O., C. Schmidt, and M. F. Mescher. 2002. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 169: 6842-6849.
21. Trambas, C. M., and G. M. Griffiths. 2003. Delivering the kiss of death. Nat. Immunol. 4: 399-403.
22. Catalfamo, M., and P. A. Henkart. 2003. Perform and the granule exocytosis cytotoxicity pathway. Curr. Opin. Immunol. 15: 522-527.
23. Trapani, J. A., and V. R. Sutton. 2003. Granzyme B: proapoptotic, antiviral and antitumor functions. Curr. Opin. Immunol. 15: 533-543.
24. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard M. J. Bevan, and_ F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
25. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335: 271-274.
26. Kranz, D. M., D. H. Sherman, M. V. Sitkovsky, M. S. Pasternack, and H. N. Eisen. 1984. Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc. Natl. Acad. Sci. USA 81: 573-577.
27. Tham, E. L., P. L. Jensen, and M. F. Mescher. 2001. Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins. J. Immunol. Methods 249: 111-119.
28. Kataoka, T., N. Shinohara, H. Takayama, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perform- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156: 3678-3686.
29. + tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J. Immunol. 167: 5042-5051.
30. Clark, R., and G. M. Griffiths. 2003. Lytic granules, secretory lysosomes and disease. Curr. Opin. Immunol. 15: 516-521.
31. Stinchcombe, J. C., D. C. Barral, E. H. Mules, S. Booth, A. N. Hume, L. M. Machesky, M. C. Seabra, and G. M. Griffiths. 2001. Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J. Cell Biol. 152: 825-834.
32. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
33. + T cells. J. Exp. Med. 199: 925-936.
34. Müllbacher, A., P. Waring, R. Tha Hla, T. Tran, S. Chin, T. Stehle, C. Museteanu, and M. M. Simon. 1999. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc. Natl. Acad. Sci. USA 96: 13950-13955.
35. Pardo, J., A. Bosque, R. Brehm, R. Wallich, J. Naval, A. Müllbacher, A. Anel, and M. M. Simon. 2004. Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis. J. Cell Biol. 167: 457-468.
36. Simon, M. M., M. Hausmann, T. Tran, K. Ebnet, J. Tschopp, R. ThaHla, and A. Müllbacher. 1997. In vitro- and ex vivo-derived cytolytic leukocytes from granzyme AXB double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J. Exp. Med. 186: 1781-1786.
37. Pardo, J., S. Balkow, A. Anel, and M. M. Simon. 2002. The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells. Eur. J. Immunol. 32: 1980-1985.
38. + T cells during primary activation. Int. Immunol. 14: 605-613.
39. + T cells in influenza virus-infected mice. Proc. Natl. Acad. Sci. USA 100: 2657-2662.
40. Regner, M., M. Lobigs, R. V. Blanden, and A. Müllbacher. 2001. Effector cytolotic function but not IFN-γ production in cytotoxic T cells triggered by virus-infected target cells in vitro. Scand. J. Immunol. 54; 366-374.
41. Rubio, V., T. B. Stuge, N. Singh, M. R. Betts, J. S. Weber, M. Roederer, and P. P. Lee. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9: 1377-1382.